Hospital-acquired pneumonia Ventilator-associated pneumonia
Regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (COVID-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19
Crohn's disease
Acute bacterial skin and skin structure infections (ABSSSI)